350 related articles for article (PubMed ID: 12183360)
1. Distinct requirements for Ras oncogenesis in human versus mouse cells.
Hamad NM; Elconin JH; Karnoub AE; Bai W; Rich JN; Abraham RT; Der CJ; Counter CM
Genes Dev; 2002 Aug; 16(16):2045-57. PubMed ID: 12183360
[TBL] [Abstract][Full Text] [Related]
2. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways.
Ward Y; Wang W; Woodhouse E; Linnoila I; Liotta L; Kelly K
Mol Cell Biol; 2001 Sep; 21(17):5958-69. PubMed ID: 11486034
[TBL] [Abstract][Full Text] [Related]
3. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
[TBL] [Abstract][Full Text] [Related]
4. Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone.
Yin J; Pollock C; Tracy K; Chock M; Martin P; Oberst M; Kelly K
Mol Cell Biol; 2007 Nov; 27(21):7538-50. PubMed ID: 17709381
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase.
McFall A; Ulkü A; Lambert QT; Kusa A; Rogers-Graham K; Der CJ
Mol Cell Biol; 2001 Aug; 21(16):5488-99. PubMed ID: 11463831
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK
Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677
[TBL] [Abstract][Full Text] [Related]
7. Interdependent action of RalGEF and Erk in Ras-induced primitive endoderm differentiation of F9 embryonal carcinoma cells.
Verheijen MH; Wolthuis RM; Defize LH; den Hertog J; Bos JL
Oncogene; 1999 Aug; 18(31):4435-9. PubMed ID: 10442634
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Ras signaling specificity by protein kinase C.
Rusanescu G; Gotoh T; Tian X; Feig LA
Mol Cell Biol; 2001 Apr; 21(8):2650-8. PubMed ID: 11283245
[TBL] [Abstract][Full Text] [Related]
9. Activation of Ras-Ral pathway attenuates p53-independent DNA damage G2 checkpoint.
Agapova LS; Volodina JL; Chumakov PM; Kopnin BP
J Biol Chem; 2004 Aug; 279(35):36382-9. PubMed ID: 15208305
[TBL] [Abstract][Full Text] [Related]
10. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
[TBL] [Abstract][Full Text] [Related]
11. Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection.
Norman KL; Hirasawa K; Yang AD; Shields MA; Lee PW
Proc Natl Acad Sci U S A; 2004 Jul; 101(30):11099-104. PubMed ID: 15263068
[TBL] [Abstract][Full Text] [Related]
12. RalGDS comes of age.
Rodriguez-Viciana P; McCormick F
Cancer Cell; 2005 Mar; 7(3):205-6. PubMed ID: 15766656
[TBL] [Abstract][Full Text] [Related]
13. Ras-dependent regulation of c-Jun phosphorylation is mediated by the Ral guanine nucleotide exchange factor-Ral pathway.
de Ruiter ND; Wolthuis RM; van Dam H; Burgering BM; Bos JL
Mol Cell Biol; 2000 Nov; 20(22):8480-8. PubMed ID: 11046144
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cathepsin L expression is mediated by different Ras effector pathways in fibroblasts and epithelial cells.
Collette J; Ulku AS; Der CJ; Jones A; Erickson AH
Int J Cancer; 2004 Nov; 112(2):190-9. PubMed ID: 15352030
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21.
Rosário M; Paterson HF; Marshall CJ
Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168
[TBL] [Abstract][Full Text] [Related]
16. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β-stimulated clone-22 is a negative-feedback regulator of Ras / Raf signaling: Implications for tumorigenesis.
Nakamura M; Kitaura J; Enomoto Y; Lu Y; Nishimura K; Isobe M; Ozaki K; Komeno Y; Nakahara F; Oki T; Kume H; Homma Y; Kitamura T
Cancer Sci; 2012 Jan; 103(1):26-33. PubMed ID: 21943131
[TBL] [Abstract][Full Text] [Related]
18. Ras-induced transformation and signaling pathway.
Yamamoto T; Taya S; Kaibuchi K
J Biochem; 1999 Nov; 126(5):799-803. PubMed ID: 10544270
[TBL] [Abstract][Full Text] [Related]
19. A novel RalGEF-like protein, RGL3, as a candidate effector for rit and Ras.
Shao H; Andres DA
J Biol Chem; 2000 Sep; 275(35):26914-24. PubMed ID: 10869344
[TBL] [Abstract][Full Text] [Related]
20. Ras oncogene induces beta-galactoside alpha2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter.
Dalziel M; Dall'Olio F; Mungul A; Piller V; Piller F
Eur J Biochem; 2004 Sep; 271(18):3623-34. PubMed ID: 15355339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
